The American Journal of Medicine
Volume 120, Issue 1 , Page e7 , January 2007

The Reply

  • Hillel W. Cohen, MPH, DrPH

      Affiliations

    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Susan M. Hailpern, MS, DrPH

      Affiliations

    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Michael H. Alderman, MD

      Affiliations

    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Jing Fang, MD

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, Ga

References 

  1. Cohen HW, Hailpern SM, Fang J, Alderman MH. Sodium intake and mortality in the NHANES II follow-up study. Am J Med. 2006;119(3):275.e7;275.e14
  2. He FJ, Wardener HE, MacGregor GA. Salt intake and cardiovascular mortality (letter). Am J Med. 2007;120:e5
  3. He J, Ogden LG, Vupputuri S, Bassano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999;282:2027–2034
  4. Tuomilehto J, Jousilahti P, Rastenyte D, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001;347:848–851
  5. Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 1995;25:1144–1152
  6. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure (The Trials of Hypertension Prevention, phase II). Arch Intern Med. 1997;157(6):657–667

 M.H.A. has been an unpaid consultant to the Salt Institute, a trade organization. Neither he, nor the other authors, has ever received research support, consulting fees, or speaker honoraria from either the Salt Institute or any other commercial entity related to use of sodium.

PII: S0002-9343(06)01132-6

doi: 10.1016/j.amjmed.2006.08.027

The American Journal of Medicine
Volume 120, Issue 1 , Page e7 , January 2007

Article Tools